SEPSIS: A MICROBIOLOGICAL, PATHOLOGICAL, AND BIOCHEMICAL PERSPECTIVE
DOI:
https://doi.org/10.25215/0557983827.08Abstract
Sepsis is a life-threatening syndrome of global clinical significance, defined by a dysregulated host response to infection that leads to progressive organ dysfunction and, in its most severe form, septic shock. It afflicts nearly 49 million individuals annually and accounts for approximately 11 million deaths worldwide, making it one of the foremost challenges in critical care medicine. This chapter examines sepsis through three converging perspectives. From a microbiological standpoint, the roles of Gram-negative and Gram-positive bacteria, fungal pathogens, and multidrug-resistant organisms are explored alongside the molecular mechanisms by which pathogen-associated molecular patterns (PAMPs), notably lipopolysaccharide (LPS), engage Toll-like receptors (TLRs) to initiate the innate immune cascade. The pathological perspective addresses the structural consequences of systemic inflammation, including endothelial glycocalyx disruption, disseminated intravascular coagulation (DIC), and multiple organ dysfunction syndrome (MODS) involving the lungs, kidneys, liver, and heart. The biochemical dimension traces the cytokine storm driven by TNF-α, IL-1β, and IL-6, the paradox of immunoparalysis, nitric oxide–mediated mitochondrial failure, cytopathic hypoxia, and the diagnostic utility of biomarkers, including procalcitonin, C-reactive protein, and serum lactate. Together, these perspectives illuminate why sepsis demands an integrated, multidisciplinary approach to both understanding and treatment.Published
2026-07-03
Issue
Section
Articles
